Table 1 Distribution of AMS symptoms at 6 h of hypoxic exposure in different groups
| Â | Groups | Â | ||||
|---|---|---|---|---|---|---|
AMS symptoms, No. (%) | Control group | Ripc group | Rapid-Ripc group | Acetazolamide group | Combined group | P value |
Headache | 24 (48.0) | 22 (44.0) | 29 (58.0) | 16 (32.0) | 16 (32.0) | 0.041 |
Gastrointestinal symptoms | 5 (10.0) | 6 (12.0) | 6 (12.0) | 5 (10.0) | 4 (8.0) | 0.963 |
Fatigue and/or weakness | 19 (38.0) | 21 (42.0) | 12 (24.0) | 14 (28.0) | 12 (24.0) | 0.168 |
Dizziness/light-headedness | 25 (50.0) | 21 (42.0) | 23 (46.0) | 20 (40.0) | 12 (24.0) | 0.084 |